Anavex Life Sciences Corp (AVXL)

[powerwalker]

nidan and plex, I received this from the Fox Foundation last week, in which it mentions a webcast tomorrow on a breakthrough in Parkinson's Disease research. It is possible the Foundation might bring up Anavex's PDD trial and OLE. [FYI - April is Parkinson's Disease Month, so it is a good month to address the disease, such as a Down Under trial with Shake It Up Foundation next Monday.]

Landmark Moment in Search for Parkinson’s Biomarker
Today, The Michael J. Fox Foundation is announcing the most significant breakthrough to date in the search for a Parkinson’s biomarker: a highly accurate biological test for Parkinson’s disease. The test is capable of objectively and reliably detecting the disease at the molecular level — even before the onset of symptoms.

This is the first biomarker capable of identifying people with Parkinson’s, or those at risk for Parkinson’s, through abnormal alpha-synuclein — the hallmark protein that misfolds in Parkinson’s — in the living brain.
READ MORE
“Validation of this biomarker launches a new, biological era in Parkinson’s research,” said Kenneth Marek, MD, Principal Investigator of the Parkinson’s Progression Markers Initiative (PPMI), MJFF’s signature clinical study of Parkinson’s biology since 2010. “This is what PPMI was built to do, and we are especially grateful to the thousands of study participants whose contributions have enabled this watershed moment.”

Read more about this milestone moment and the Foundation’s leadership role.

Tune in next week for a special edition Third Thursdays Webinar to learn more about this discovery and how it will speed development of better treatments. Register now to submit questions for our experts in advance
Thursday, April 20, 12 p.m. ET

I am deeply moved by this breakthrough and grateful to the researchers, study participants and funders who have endeavored to bring us this far.

— Michael J. Fox